No longer just “the big company advantage,” CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
No longer just “the big company advantage,” Arlen Ward discusses how CM&S is an accepted and viable device industry path to market for large and small medical device makers alike.
The center intends to facilitate partnerships, exchange knowledge and promote innovative regulatory approaches.
Leveraging automation and data analytics can help facilitate innovation and financial stability.
The IGNITE American Innovation Act aims to help small- and mid-sized businesses affected by the COVID-19 pandemic.
The winning innovators will receive grant awards of upwards of $50,000.
With the rapid growth of life tech discoveries, there is a need to adapt the patent and regulatory frameworks governing the approval, use, and protection of such discoveries.
As COVID-19 sweeps the globe, it’s becoming increasingly difficult for medical device leaders to navigate the arising challenges and prepare for the future.
The pace of innovation in the ICU is orders of magnitude slower than that of the cath lab and OR, and the COVID-19 crisis has pushed, tested, and exposed ICUs for lacking state-of-the-art technology and resources.
Illumina’s COVIDSeq Test enables qualitative detection of SARS-CoV-2 RNA from respiratory specimens.